Halt Medical Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Halt Medical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014393
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It offers products for treatment of percutaneous, laparoscopic coagulation, ablation of soft tissue, and symptomatic uterine fibroids under laparoscopic ultrasound guidance. Halt Medical offers services such as heavy menstrual bleeding, pain, bloating, and other debilitating fibroid symptoms detection and treatment, multi centre clinical trials, invasive surgical procedures, fibroids treatment services, clinical studies, and uterine-conserving study procedures. Its technologies include radiofrequency volumetric thermal ablation, fibroid treatment algorithm, and laparoscopic ultrasound in fibroid treatment. Halt Medical is headquartered in Brentwood, California, the US.

Halt Medical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halt Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Halt Medical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Halt Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Halt Medical Raises US$29.5 Million In Venture Financing 11
Halt Medical Raises US$0.5 Million In Venture Financing 12
Halt Medical Raises US$3 Million In Venture Financing 13
Halt Medical Inc – Key Competitors 14
Halt Medical Inc – Key Employees 15
Halt Medical Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Mar 22, 2016: Kim Bridges joins Halt Medical as President and Chief Executive Officer 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Halt Medical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halt Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halt Medical Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Halt Medical Inc, Medical Devices Deals, 2011 to YTD 2017 9
Halt Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Halt Medical Raises US$29.5 Million In Venture Financing 11
Halt Medical Raises US$0.5 Million In Venture Financing 12
Halt Medical Raises US$3 Million In Venture Financing 13
Halt Medical Inc, Key Competitors 14
Halt Medical Inc, Key Employees 15

★海外企業調査レポート[Halt Medical Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • China Power Clean Energy Development Co Ltd (735):電力:M&Aディール及び事業提携情報
    Summary China Power Clean Energy Development Co Ltd (CPCE) formerly China Power New Energy Development Co Ltd, is an electric utility. It develops, constructs, owns, operates, and manages clean energy power plants. The company produces electricity through natural gas, wind, hydro, and solar sources. …
  • Pilgrim’s Pride Corporation:企業の戦略・SWOT・財務情報
    Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report Summary Pilgrim's Pride Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cloud Live Technology Group Co. Ltd.:企業の戦略・SWOT・財務分析
    Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cloud Live Technology Group Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • China Foods Ltd:企業の戦略・SWOT・財務分析
    China Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary China Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Dance Biopharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Tecpetrol S.A.:企業の戦略・SWOT・財務情報
    Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Hut Group Ltd:企業のM&A・事業提携・投資動向
    The Hut Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Hut Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Scripps Networks Interactive, Inc.:企業のM&A・事業提携・投資動向
    Scripps Networks Interactive, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Scripps Networks Interactive, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ellex Medical Lasers Limited (ELX):医療機器:M&Aディール及び事業提携情報
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Allahabad Bank (ALBK)
    Allahabad Bank (ALBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Monica Healthcare Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Monica Healthcare Ltd (MHL), a subsidiary of GE Healthcare LLC, is a medical device company that develops and commercializes fetal monitoring devices for use during labor and uterine activity applications. The company provides products such as monica AN24 with IF24, monica AN24 with VS progr …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • FDM Group (Holdings) plc (FDM):企業の財務・戦略的SWOT分析
    FDM Group (Holdings) plc (FDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • AutoNation, Inc. (AN):企業の財務・戦略的SWOT分析
    AutoNation, Inc. (AN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Scioderm Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scioderm Inc (Scioderm), a subsidiary of Amicus Therapeutics Inc is a clinical stage biopharmaceutical company that develops various therapies. The company develops novel therapies for conditions including orphan diseases. Its product include Zorblisa (SD-101), is developed for treating the …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GKE Corporation Limited (595):企業の財務・戦略的SWOT分析
    GKE Corporation Limited (595) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆